Live News EQUITY H impact Jun 25, 2026, 01:23 PM UTC

NRSN Reports Positive Biomarker Findings

NeuroSense reports positive biomarker findings from Phase 2 RoAD proof-of-concept study of PrimeC in Alzheimer's disease

SQUAWKNEWS Updated Jun 25, 2026, 01:23 PM UTC

NRSN - NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease